SCHEMBL660962

SCHEMBL660962

COC(=O)OCCOC(=O)C1=CN(CC(=O)c2ccccc2)C=CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.41
L3MBTL1 Q9Y468 2/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TSHR P16473 3/20 0.35
LMNA P02545 1/20 0.35
NPC1 O15118 4/20 0.35
MEN1 O00255 3/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
ALDH1A1 P00352 3/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL661158 0.90 TDP1 (0.44) KMT2AL3MBTL1LMNANPC1SLC6A3
SCHEMBL658507 0.87 TSHR (0.42) KMT2AL3MBTL1POLBHTTNPSR1
SCHEMBL660364 0.81 PDCD1 (0.43) KMT2AL3MBTL1POLBHTTNPSR1
SCHEMBL27854995 0.78 ALDH1A1 (0.41) KMT2ATSHRNPC1MEN1TDP1
SCHEMBL298474 0.77 SMN1; SMN2 (0.40) KMT2ATSHRNPC1MEN1TDP1
SCHEMBL660917 0.77 ALDH1A1 (0.40) KMT2ATSHRNPC1MEN1TDP1
SCHEMBL660154 0.76 SMN1; SMN2 (0.39) KMT2ATSHRNPC1MEN1TDP1
SCHEMBL27871677 0.76 ALDH1A1 (0.38) KMT2ATSHRLMNANPC1MEN1
SCHEMBL298933 0.76 RAB9A (0.40) KMT2AL3MBTL1POLBTSHRNPC1
SCHEMBL7805087 0.75 HDAC1 (0.40) KMT2ANPC1MEN1TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US claimed
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT KMT2A 4512/4885L3MBTL1 4711/4885POLB 2267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.